活性成分Active Ingredient

Caohe Che (草河车)草河车

This is an ingredient/substance record as used in registered products or formulas.本页为注册药品或方剂中使用的成分/物质记录。

What we know已知信息

  • Recorded name (CN)已记录名称: 草河车
  • Record kind: ingredient/substance as used in registered products or formulas记录类型：注册药品或方剂中使用的成分/物质
  • Registered medicines on this record本页已记录的注册药品数: 114
  • Recorded product types已记录产品类型数: 2
  • Recorded dosage forms已记录剂型数: 2
  • Manufacturers on recorded products已记录生产企业数: 113
  • Product links on this page本页药品链接数: 16

No product-level labeled indications/safety are joined for this record.本记录未接入产品级适应症/安全性标注字段。

在药品知识图谱中有 114 条已注册药品记录。114 registered medicine records in MedicineGraph.
点击右上角 EN 切换为英文界面Switch to English with the EN button above
114
注册药品Registered medicines
2
产品类型Product types
2
剂型Dosage forms
113
生产企业Manufacturers
关键洞察Key Insight大多数含草河车的药品是乙肝解毒胶囊（胶囊剂），由113家企业生产（与上方生产企业统计一致）。药品差异主要体现在生产企业和包装规格上。Most medicines containing 草河车 are 乙肝解毒胶囊 (胶囊剂), linked to 113 manufacturers overall (same as Manufacturers card above). Products differ mainly in manufacturer and packaging.

产品类型分布Product Type Distribution

乙肝解毒胶囊 胶囊剂
113 条记录records (99.1%) . 113 家企业companies
庆余辟瘟丹 未标注
1 条记录records (0.9%) . 1 家企业companies

剂型分布Dosage Form Distribution

胶囊剂
113 (99.1%)
未标注
1 (0.9%)

主要生产企业Top Manufacturing Companies

Manufacturers listed because they appear on products recording this ingredient.下列企业因出现在含本成分的已记录药品上而列出。

杭州胡庆余堂药业有限公司Chinese legal name: 杭州胡庆余堂药业有限公司
2 条相关记录related records
吉林省天泰药业股份有限公司Chinese legal name: 吉林省天泰药业股份有限公司
1 条相关记录related records
通化斯威药业股份有限公司Chinese legal name: 通化斯威药业股份有限公司
1 条相关记录related records
吉林方大药业集团股份有限公司Chinese legal name: 吉林方大药业集团股份有限公司
1 条相关记录related records
长沙东风药业有限公司Chinese legal name: 长沙东风药业有限公司
1 条相关记录related records
西安碑林药业股份有限公司Chinese legal name: 西安碑林药业股份有限公司
1 条相关记录related records
四川彩虹制药有限公司Chinese legal name: 四川彩虹制药有限公司
1 条相关记录related records
东莞市亚洲制药有限公司Chinese legal name: 东莞市亚洲制药有限公司
1 条相关记录related records
通化振霖药业有限责任公司Chinese legal name: 通化振霖药业有限责任公司
1 条相关记录related records
成都九芝堂金鼎药业有限公司Chinese legal name: 成都九芝堂金鼎药业有限公司
1 条相关记录related records

代表性产品Representative Products

乙肝解毒胶囊Yigan Jiedu Jiaonang
吉林省天泰药业股份有限公司 | 每粒装0.25g | Registration: 国药准字Z22025777
乙肝解毒胶囊Yigan Jiedu Jiaonang
通化斯威药业股份有限公司 | 每粒装0.25g | Registration: 国药准字Z22022695
乙肝解毒胶囊Yigan Jiedu Jiaonang
吉林方大药业集团股份有限公司 | 每粒装0.25g | Registration: 国药准字Z22020311
乙肝解毒胶囊Yigan Jiedu Jiaonang
长沙东风药业有限公司 | 每粒装0.25g | Registration: 国药准字Z43020390
乙肝解毒胶囊Yigan Jiedu Jiaonang
杭州胡庆余堂药业有限公司 | 每粒重0.25g | Registration: 国药准字Z33020113
乙肝解毒胶囊Yigan Jiedu Jiaonang
西安碑林药业股份有限公司 | 每粒重0.25g | Registration: 国药准字Z61020931
乙肝解毒胶囊Yigan Jiedu Jiaonang
四川彩虹制药有限公司 | 每粒重0.25g | Registration: 国药准字Z51021783
乙肝解毒胶囊Yigan Jiedu Jiaonang
东莞市亚洲制药有限公司 | 每粒重0.25g | Registration: 国药准字Z44021658

数据局限性Data Limitations

  • 药品知识图谱不提供适应症、用法用量、禁忌症或用药建议。MedicineGraph does not provide indications, dosage, contraindications, or medication advice.
  • 数据来自药品注册数据库，不代表完整目录。Data comes from medicine registration databases. This is not a complete catalog.
关于数据质量About Data Quality
Total records: 114
Band: 101-250
Mode: STANDARD_KNOWLEDGE_PAGE
Product families: 2
Name resolution: 2/114
Generated: 2026-08-20
Version: Phase 30.7 V3 Adaptive Full Family

这是什么What is this

本段仅展示图谱已记录的身份信息，不含适应症、用法或疗效主张。Identity from recorded graph fields only; no indications, dosing, or efficacy claims.

含该成分的药品（已记录）Products containing this ingredient

Products listed because they record this ingredient.下列药品因记录含有本成分而列出。

关联实体Relationships

Manufacturers listed because they appear on products recording this ingredient.下列企业因出现在含本成分的已记录药品上而列出。

信息来源与范围Source and scope

MedicineGraph 已记录实体与精确关系；非完整目录。不推断未记录的临床属性。MedicineGraph recorded entities and exact relationships only; not a complete catalog. No inferred clinical attributes.

信息来源Source and scope

国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.